The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s ...

Japanese drugmakers Mochida Pharmaceutical and Marubeni Pharmaceutical announced that Mochida has obtained new drug approval ...

Shares of Danish biotech Genmab fell as much as 5% on Friday, after is released disappointing top-line clinical results for ...

Sweden’s Sobi has announced that the European Commission (EC) has approved Aspaveli (pegcetacoplan) for adults and ...

As many as four decisions under the US Food and Drug Administration’s (FDA) new fast-track program have been delayed, Reuters ...

WuXi XDC has made a bid to buy fellow Chinese firm BioDlink, a fully integrated CDMO offering end-to-end biologics ...

Effective January1, 2026, STADA Arzneimitel’s global head of communications, Frank Staud, is additionally assuming global ...

Russian customers are forced to save on drug purchases these days due to the ever-growing prices, falling incomes, and the ...

Japanese drugmaker Tanabe Pharma said its oral candidate dersimelagon met the primary endpoint and showed a favorable safety ...

Italian non-profit organization Fondazione Telethon today announced the European Commission’s decision of January 9, to grant ...

US biologics CDMO Avid Bioservices (Nasdaq: CDMO) has appointed Rich McAvoy as chief business officer, as the company talks ...

Eisai has reached a license agreement with Nuvation Bio, a global oncology company focused on tackling some of the toughest ...